MedTrace Logo

Purified Anthocyanin and Nonalcoholic Fatty Liver Disease

NCT01940263 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2014-08-01

No results posted yet for this study

Summary

Oxidative stress and inflammation are involved in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Anthocyanins from different plant foods have been shown to improve features of experimental NASH, such as oxidative stress, dyslipidemia, liver steatosis, and inflammation in rodents. The purpose of this study is to investigate whether purified anthocyanin supplementation beneficially alters oxidative, inflammatory, and apoptotic biomarkers in adults with features of NAFLD.

Conditions

  • Nonalcoholic Fatty Liver Disease

Interventions

DIETARY_SUPPLEMENT

Anthocyanin

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Shaoguan University

    lead OTHER

Principal Investigators

  • Wenhua Ling, Ph.D · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-01-31
Completion
2014-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01940263 on ClinicalTrials.gov